in Healthcare IT, News
SRI Int’l to Support Anti-Cancer Vaccine Studies for NIH Center
SRI International will carry out pre-clinical studies on compounds and vaccines to determine if they can act as preventive agents against cancer under a $19.8 million contract with a National Institutes of Health center. The company said Thursday its biosciences division will work to examine the effectiveness of experimental vaccines and test biomarkers in an effort to parallel how the body responds […] More